Gynecology Drugs Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery

Jul 2022| TBR1409C| TBRC (Publisher)

Report Highlights

Including: 1) By Therapeutics: Hormonal Therapy; Non-Hormonal Therapy
2) By Indication: Gynecological Cancers; Menopausal Disorder; Polycystic Ovary Syndrome; Contraception; Others
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Covering: Merck & Co. Inc.; AbbVie; Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc; Pfizer Inc.

Gynecology Drugs Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gynecology drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Description:
Where is the largest and fastest growing market for gynecology drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The gynecology drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider gynecology drugs market; and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction– The introduction section of the report gives brief introduction about segmentation by geography, segmentation by therapeutics, segmentation by indication and segmentation by distribution channel.
  • Market Characteristics – The market characteristics section of the report defines and explains the gynecology drugs market. This section also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This section describes the major trends shaping the global gynecology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the gynecology drugs market.
  • Global Market Size And Growth – This section contains the global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2016-2031) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2021), historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global gynecology drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This section gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for gynecology drugs providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Frequently Asked Questions (FAQs)

Scope:

Markets Covered:

  • By Therapeutics: Hormonal Therapy; Non-Hormonal Therapy
  • By Indication: Gynecological Cancers; Menopausal Disorder; Polycystic Ovary Syndrome; Contraception; Others
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Merck & Co. Inc.; AbbVie; Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc; Pfizer Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; gynecology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 2 : Global Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3 : Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4 : Global Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5 : Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6 : Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7 : Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8 : Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9 : Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10 : Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11 : Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12 : Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13 : Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 14 : Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 15 : Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 16 : Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 17 : Asia-Pacific Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 18 : Asia-Pacific Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
  • Table 19 : Asia-Pacific Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 20 : Asia-Pacific Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 21 : Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 22 : Asia-Pacific Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 23 : China GDP Per Capita, 2015-2020, $
  • Table 24 : China, Population By Age Group, 2015-2025, Thousands
  • Table 25 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 26 : China Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 27 : China Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, 2016-2026, $ Billion
  • Table 28 : China Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 29 : China Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 30 : China Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 31 : China Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 32 : India Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 33 : India Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 34 : India Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 35 : India Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 36 : Japan Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 37 : Japan Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 38 : Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39 : Japan Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40 : Australia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 41 : Australia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 42 : Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 43 : Australia Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 44 : Indonesia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 45 : Indonesia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 46 : Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 47 : Indonesia Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 48 : South Korea Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 49 : South Korea Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 50 : South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51 : South Korea Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52 : Western Europe GDP Per Capita, 2015-2020, $
  • Table 53 : Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 54 : Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 55 : Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 56 : Western Europe Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 57 : Western Europe Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
  • Table 58 : Western Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 59 : Western Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 60 : Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 61 : Western Europe Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 62 : UK Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 63 : UK Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 64 : UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 65 : UK Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 66 : Germany Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 67 : Germany Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 68 : Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 69 : Germany Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 70 : France Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 71 : France Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 72 : France Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 73 : France Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 74 : Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 75 : Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 76 : Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 77 : Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 78 : Eastern Europe Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 79 : Eastern Europe Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
  • Table 80 : Eastern Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 81 : Eastern Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 82 : Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 83 : Eastern Europe Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 84 : Russia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 85 : Russia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 86 : Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 87 : Russia Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 88 : North America GDP Per Capita, 2015-2020, $
  • Table 89 : North America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 90 : North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 91 : North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 92 : North America Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 93 : North America Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
  • Table 94 : North America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 95 : North America Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 96 : North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 97 : North America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 98 : USA GDP Per Capita, 2015-2020, $
  • Table 99 : USA, Population By Age Group, 2015-2025, Thousands
  • Table 100 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 101 : USA Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 102 : USA Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, 2016-2026, $ Billion
  • Table 103 : USA Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 104 : USA Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 105 : USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 106 : USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 107 : South America GDP Per Capita, 2015-2020, $
  • Table 108 : South America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 109 : South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 110 : South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 111 : South America Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 112 : South America Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
  • Table 113 : South America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 114 : South America Drugs market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 115 : South America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 116 : South America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 117 : Brazil Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 118 : Brazil Drugs market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 119 : Brazil Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 120 : Brazil Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 121 : Middle East GDP Per Capita, 2015-2020, $
  • Table 122 : Middle East, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 123 : Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 124 : Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 125 : Middle East Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 126 : Middle East Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
  • Table 127 : Middle East Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 128 : Middle East Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 129 : Middle East Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 130 : Middle East Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 131 : Africa GDP Per Capita, 2015-2020, $
  • Table 132 : Africa, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 133 : Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 134 : Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 135 : Africa Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 136 : Africa Gynecology Drugs Market, Pharmaceuticals Drugs Market Size, By Country, 2016-2026, $ Billion
  • Table 137 : Africa Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 138 : Africa Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 139 : Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 140 : Africa Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 141 : Global Gynecology Drugs Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Table 142 : Merck & Co. Inc. – Financial Overview, 2017 - 2021, $ Billion
  • Table 143 : AbbVie – Financial Overview, 2017 - 2021, $ Billion
  • Table 144 : F. Hoffmann-La Roche Ltd. – Financial Overview, 2017 - 2021, $ Billion
  • Table 145 : GlaxoSmithKline Plc – Financial Overview, 2017 - 2021, $ Billion
  • Table 146 : Pfizer Inc. – Financial Overview, 2017 - 2021, $ Billion
  • Table 147 : Global Gynecology Drugs Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 148 : Global Gynecology Drugs Market Size Gain ($ Million), Segmentation By Therapeutics, 2021 – 2026
  • Table 149 : Global Gynecology Drugs Market Size Gain ($ Million), Segmentation By Indication, 2021 – 2026
  • Table 150 : Global Gynecology Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2021 – 2026
  • Table 151 : Gynecology Drugs - Market Data Sources
  • Figure 1 : Global Gynecology Drugs Market Segmentation By Therapeutics
  • Figure 2 : Global Gynecology Drugs Market Segmentation By Indication
  • Figure 3 : Global Gynecology Drugs Market Segmentation By Distribution Channel
  • Figure 4 : Global Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 5 : Global Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 6 : Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 7 : Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 8 : Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 9 : Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10 : Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 11 : Asia-Pacific Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 12 : Asia-Pacific Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 13 : Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 14 : China Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 15 : China Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 16 : China Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 17 : India Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 18 : India Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 19 : India Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 20 : Japan Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 21 : Japan Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 22 : Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 23 : Australia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 24 : Australia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 25 : Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 26 : Indonesia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 27 : Indonesia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 28 : Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 29 : South Korea Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 30 : South Korea Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 31 : South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 32 : Western Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 33 : Western Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 34 : Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 35 : UK Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 36 : UK Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 37 : UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 38 : Germany Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 39 : Germany Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 40 : Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 41 : France Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 42 : France Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 43 : France Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 44 : Eastern Europe Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 45 : Eastern Europe Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 46 : Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 47 : Russia Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 48 : Russia Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 49 : Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 50 : North America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 51 : North America Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 52 : North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 53 : USA Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 54 : USA Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 55 : USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 56 : South America Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 57 : South America Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 58 : South America Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 59 : Brazil Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 60 : Brazil Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 61 : Brazil Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 62 : Middle East Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 63 : Middle East Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 64 : Middle East Gynecology Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 65 : Africa Gynecology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 66 : Africa Gynecology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 67 : Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 68 : Global Gynecology Drugs Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Figure 69 : Merck & Co. Inc. – Financial Overview, 2017 – 2021, $ Billion
  • Figure 70 : AbbVie – Financial Overview, 2017 – 2021, $ Billion
  • Figure 71 : F. Hoffmann-La Roche Ltd. – Financial Overview, 2017 – 2021, $ Billion
  • Figure 72 : GlaxoSmithKline Plc – Financial Overview, 2017 – 2021, $ Billion
  • Figure 73 : Pfizer Inc. – Financial Overview, 2017 – 2021, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Gynecology Drugs Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR1409B

Including: 1) By Therapeutics: Hormonal Therapy; Non-Hormonal Therapy
2) By Indication: Gynecology Cancers; Menopausal Disorder; Polycystic Ovary Syndrome; Contraception; Others
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Covering: Hoffmann-La Roche Ltd.; Pfizer inc.; Merck & Co. inc.; Allergan; AstraZeneca; Bayer AG; AbbVie; TherapeuticsMD inc.

Gynecology Drugs Global Market Report 2022 from The Business Research Company provides the ...

Gynecology Drugs Global Market Report 2021: COVID-19 Growth And Change

  • Date - Jul 2021
  • Code - TBR1409A

Including: 1) By Therapeutics: Hormonal Therapy; Non-Hormonal Therapy
2) By Indication: Gynecology Cancers; Menopausal Disorder; Polycystic Ovary Syndrome; Contraception; Others
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Covering: Hoffmann-La Roche Ltd.; Pfizer Inc; Merck & Co. Inc.; Allergan; AstraZeneca

Gynecology Drugs Global Market Report 2021: COVID-19 Growth And Change from The Business Research Company provides the strategists, ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS